EW Edwards Lifesciences Earnings and EPS analysis

  1. Stocks
  2. Healthcare
  3. NYSE: EW
  4. Earnings
?
Relative Growth: Rel. Growth: 46
Relative Strength: Rel. Strength: 50
Relative Valuation: Rel. Valuation: 17
Relative Profitability: Rel. Profitability: 68

EPS in 2026 (TTM): $1.74

Last Report Period Date: Jun 30, 2026

As of August 2026, according to Edwards Lifesciences's latest financial report, the company's current EPS (TTM) is $1.74. Edwards Lifesciences's EPS for 2025 came in at $1.84, marking a decrease from $6.98 in 2024. Edwards Lifesciences's earnings per share for the quarterly report ending on Jun 30, 2026 was $0.42.

EW earnings history

Historical annual and quarterly earnings per share (EPS) data for Edwards Lifesciences
EPS (TTM)
$1.74
EPS Growth YoY (Quarterly)
-26.3%
EPS (Quarterly)
$0.42
EPS Growth (Quarterly)
-36.4%

The annual EPS in 2025 was $1.84, a decrease of 73.6% from $6.98 in 2024. The quarterly EPS for the period ending Jun 30, 2026, was $0.42, marking a 26.3% decrease from the same quarter last year. EW's TTM EPS stands at $1.74 as of June 2026. Edwards Lifesciences's EPS for 2024 stood at $6.98, a 202.2% increase from 2023.

EW EPS vs price chart

EW EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
-26.3%
EPS growth YoY
-73.6%
EPS growth 3Y avg
-9.2%
EPS growth 5Y avg
6.9%

Edwards Lifesciences has recorded a decrease in EPS of 26.3% over the last 12 months (YoY, quarterly). For the last three years, EW recorded an average annual EPS growth rate of -9.2%. Edwards Lifesciences had an average annual EPS growth rate of 6.9% over the last 5 years. Across the last decade, EW had an average annual EPS growth of 9.1%.

EW Earnings Waterfall

Breakdown of revenue, profit and net income for Edwards Lifesciences

EW Earnings vs Peers

What are the earnings of EW compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
BSX Boston Scientific Corp 20.23 55.6% 63.3% N/A
MDT Medtronic Plc 24.89 3.3% 9.8% 6.9%
LMAT Lemaitre Vascular Inc 28.23 30.1% 39.5% 19.4%
MMSI Merit Medical Systems Inc 37.05 4.8% 18.3% N/A
EW Edwards Lifesciences Corp 51.6 -73.6% -9.2% 6.9%
ICUI ICU Medical Inc 152.37 100.6% N/A -62.7%

All data is based on quarterly TTM periods, unless otherwise specified.